T1	Chemical	52 61	gefitinib
T2	Chemical	66 82	erlotinib induce
T3	Pharmacodynamic_phenotype	83 95	responses in
T4	Disease	109 123	NSCLC patients
T5	Limited_variation	134 155	EGFR mutations , with
T6	Phenotype	156 183	progression-free survival (
T7	Phenotype	188 197	) ranging
R1	influences	Arg1:T1	Arg2:T2
R2	causes	Arg1:T1	Arg2:T3
R3	treats	Arg1:T1	Arg2:T4
R4	treats	Arg1:T1	Arg2:T5
R5	influences	Arg1:T2	Arg2:T1
R6	causes	Arg1:T2	Arg2:T3
R7	treats	Arg1:T2	Arg2:T4
R8	influences	Arg1:T3	Arg2:T1
R9	influences	Arg1:T3	Arg2:T2
R10	treats	Arg1:T3	Arg2:T4
R11	isAssociatedWith	Arg1:T3	Arg2:T5
R12	isAssociatedWith	Arg1:T3	Arg2:T6
R13	isAssociatedWith	Arg1:T3	Arg2:T7
R14	isAssociatedWith	Arg1:T4	Arg2:T1
R15	isAssociatedWith	Arg1:T4	Arg2:T2
R16	isAssociatedWith	Arg1:T4	Arg2:T3
R17	isAssociatedWith	Arg1:T4	Arg2:T5
R18	isAssociatedWith	Arg1:T4	Arg2:T6
R19	isAssociatedWith	Arg1:T4	Arg2:T7
R20	isAssociatedWith	Arg1:T5	Arg2:T1
R21	isAssociatedWith	Arg1:T5	Arg2:T2
R22	isAssociatedWith	Arg1:T5	Arg2:T3
R23	isAssociatedWith	Arg1:T5	Arg2:T4
R24	isAssociatedWith	Arg1:T5	Arg2:T6
R25	isAssociatedWith	Arg1:T5	Arg2:T7
R26	isAssociatedWith	Arg1:T6	Arg2:T1
R27	isAssociatedWith	Arg1:T6	Arg2:T2
R28	isAssociatedWith	Arg1:T6	Arg2:T3
R29	isAssociatedWith	Arg1:T6	Arg2:T4
R30	isAssociatedWith	Arg1:T6	Arg2:T5
R31	isAssociatedWith	Arg1:T6	Arg2:T7
R32	isAssociatedWith	Arg1:T7	Arg2:T1
R33	isAssociatedWith	Arg1:T7	Arg2:T2
R34	isAssociatedWith	Arg1:T7	Arg2:T3
R35	isAssociatedWith	Arg1:T7	Arg2:T4
R36	isAssociatedWith	Arg1:T7	Arg2:T5
R37	isEquivalentTo	Arg1:T7	Arg2:T6
